Liposuction as Treatment for Excessive Axillary Sweat

This study has been completed.
Sponsor:
Information provided by:
Odense University Hospital
ClinicalTrials.gov Identifier:
NCT00228072
First received: September 26, 2005
Last updated: May 28, 2008
Last verified: May 2008
  Purpose

The purpose of this study is to determine if suction-curettage of the axilla is favorable in regard to effect, recovery and cosmetic appearance compared to standard surgical excision of the skin of the axilla in case of excessive sweating.


Condition Intervention Phase
Hyperhidrosis
Procedure: Suction-curettage
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Suction-Curettage vs. Standard Excision in Axillary Hyperhidrosis

Resource links provided by NLM:


Further study details as provided by Odense University Hospital:

Estimated Enrollment: 50
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Detailed Description:

The surgical standard treatment for isolated excessive axillary sweating is excision of the hair-bearing area of the axilla. This technique is associated with a risk of impaired wound healing, infections, wide scars and a risk of impairment in the movement of the arm (seldom).

A new technique suction-curettage, much alike the liposuction technique, in which the dermis is curettage from a sub-dermal approach with a cutting and sucking devise, may be promising in regard to recovery and cosmetic appearance postoperatively, but the effect of the sweat production is not well known. This study compares liposuction vs. standard excision in individuals with isolated excessive isolated axillary sweating randomized to treatment with one of each technique in both axillas.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult individuals with primary axillary hyperhidrosis

Exclusion Criteria:

  • Secondary axillary hyperhidrosis
  • Hidrosadenitis axillaris/inguinalis
  • Prior surgery
  • Iontophoresis or botox treatment 12 months prior
  • Known hypersensitivity to local analgetics (lidocaine)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00228072

Locations
Denmark
Department of Plastic Surgery, Odense University Hospital
Odense, Fyn, Denmark, DK-5000
Sponsors and Collaborators
Odense University Hospital
Investigators
Study Chair: Finn Gottrup, DMsci University Center of Wound Healing, Dept. of Plastic Surgery, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark
Study Director: Torben Moeller-Christensen, MD Department of Plastic Surgery, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00228072     History of Changes
Other Study ID Numbers: VF20030189
Study First Received: September 26, 2005
Last Updated: May 28, 2008
Health Authority: Denmark: National Board of Health

Keywords provided by Odense University Hospital:
Hyperhidrosis
Axillary
Excision
Suction-curettage
Outcome

Additional relevant MeSH terms:
Hyperhidrosis
Sweat Gland Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 28, 2014